M&A Due Diligence Doesn't Wait for You to Be Ready

Healthcare deals live and die on more than the P&L. Buyers now dig deep into compliance, data privacy, and information security before they'll commit to a price — and what they find changes that price. Waiting until a term sheet is on the table to get your house in order is one of the most common, and most costly, mistakes a seller can make.

It's Not a Side Diligence Track Anymore

Cybersecurity and compliance diligence used to sit alongside the financial review. Now they're inseparable from it. Buyers routinely ask for HIPAA security risk analyses, breach history, business associate agreement files, and evidence of an actual compliance program — not just a policy binder. A target that can't produce this documentation cleanly signals risk before a single number is discussed.

Where This Hits Valuation

• Purchase price adjustments and escrows. Undisclosed gaps in compliance or security controls routinely translate into holdbacks, specific indemnities, or a lower multiple.
• Deal delays or collapse. Findings that surface late in diligence can stall a closing timeline or kill a deal outright.
• Post-close liability. A buyer inherits a target's regulatory exposure the moment the deal closes — undisclosed billing issues, referral arrangements, or open investigations become their problem, and your negotiation weakness.
• Data privacy exposure beyond HIPAA. Buyers are now checking alignment with state consumer health data laws too, not just federal rules — a gap many sellers don't think to close.

The Compliance Side Buyers Dig Into

Privacy and security get the headlines, but a buyer's compliance review is often broader and just as consequential:

• Fraud and abuse exposure. Referral arrangements, physician compensation, and medical director agreements get tested against Stark Law and the Anti-Kickback Statute. A single non-compliant arrangement can create liability that follows the deal.
• Billing and coding integrity. Buyers sample claims data looking for patterns of upcoding, unsupported medical necessity, or improper billing under government programs — all potential False Claims Act exposure.
• Licensure and accreditation. Expired licenses, missing NPI or Medicare/Medicaid enrollment records, and accreditation gaps are common, easily-missed red flags that stall closings.
• Exclusion and sanction screening. Buyers confirm that no owners, employees, or contracted providers appear on the OIG exclusion list or state sanction databases — an area that's simple to get wrong through inconsistent monitoring.
• Prior investigations and corrective history. Any history of self-disclosures, Corporate Integrity Agreements, audits, or government inquiries gets scrutinized, along with whether findings were actually remediated.
• Program governance. Buyers want to see a functioning compliance program, not just a policy binder — a designated compliance officer, a working compliance committee, documented risk assessments, and evidence of ongoing auditing and monitoring.

What Buyers Are Actually Looking For

• A documented, functioning compliance program — written policies, an empowered compliance officer, and a track record of risk assessments and internal audits
• Clean referral and compensation arrangements, reviewed for Stark Law and AKS exposure
• Billing and coding practices that hold up under sampling
• Current licenses, accreditations, and payer enrollments
• Documented HIPAA policies, a current security risk analysis, and a risk management plan with real timelines
• A complete BAA inventory with vendors and business partners
• Breach and incident history, plus a tested incident response plan
• Alignment with state privacy obligations that may apply beyond HIPAA's scope

Preparation Is Leverage

None of this is a reason to panic — it's a reason to get ahead of it. Sellers who complete their own compliance, privacy, and security review before going to market walk into diligence with answers instead of surprises, and that composure shows up in the number on the offer.

CohesiveIQ helps healthcare organizations get M&A-ready: identifying gaps before a buyer does, tightening documentation, and building the kind of clean compliance record that supports — rather than undermines — your valuation.

Preparing for a transaction, or already in one? CohesiveIQ can help you get ready. Contact us to talk through where you stand.

‍